KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Invested Capital (2020 - 2025)

Novavax has reported Return on Invested Capital over the past 8 years, most recently at 3.22% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 3.22% for Q4 2025, down 371.0% from a year ago — trailing twelve months through Dec 2025 was 3.22% (down 371.0% YoY), and the annual figure for FY2025 was 1.31%, down 173.0%.
  • Return on Invested Capital for Q4 2025 was 3.22% at Novavax, up from 5.03% in the prior quarter.
  • Over the last five years, Return on Invested Capital for NVAX hit a ceiling of 9.06% in Q1 2022 and a floor of 31.28% in Q4 2021.
  • Median Return on Invested Capital over the past 5 years was 0.5% (2024), compared with a mean of 1.78%.
  • Biggest five-year swings in Return on Invested Capital: surged 3236bps in 2022 and later tumbled -1858bps in 2025.
  • Novavax's Return on Invested Capital stood at 31.28% in 2021, then soared by 103bps to 1.08% in 2022, then decreased by -25bps to 0.82% in 2023, then plummeted by -40bps to 0.49% in 2024, then crashed by -764bps to 3.22% in 2025.
  • The last three reported values for Return on Invested Capital were 3.22% (Q4 2025), 5.03% (Q3 2025), and 18.12% (Q2 2025) per Business Quant data.